AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 294: F971-F981, 2008. First published February 13, 2008; doi:10.1152/ajprenal.00313.2007
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/F971    most recent
00313.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kullmann, F. A.
Right arrow Articles by Birder, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kullmann, F. A.
Right arrow Articles by Birder, L. A.

Heterogeneity of muscarinic receptor-mediated Ca2+ responses in cultured urothelial cells from rat

F. Aura Kullmann,1 D. Artim,1 J. Beckel,1,2 S. Barrick,1 W. C. de Groat,1 and L. A. Birder1,2

Departments of 1Pharmacology and 2Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Submitted 9 July 2007 ; accepted in final form 11 February 2008

Muscarinic receptors (mAChRs) have been identified in the urothelium, a tissue that may be involved in bladder sensory mechanisms. This study investigates the expression and function of mAChRs using cultured urothelial cells from the rat. RT-PCR established the expression of all five mAChR subtypes. Muscarinic agonists acetylcholine (ACh; 10 µM), muscarine (Musc; 20 µM), and oxotremorine methiodide (OxoM; 0.001–20 µM) elicited transient repeatable increases in the intracellular calcium concentration ([Ca2+]i) in ~50% of cells. These effects were blocked by the mAChR antagonist atropine methyl nitrate (10 µM). The sources of [Ca2+]i changes included influx from external milieu in 63% of cells and influx from external milieu plus release from internal stores in 27% of cells. The use of specific agonists and antagonists (10 µM M1 agonist McN-A-343; 10 µM M2, M3 antagonists AF-DX 116, 4-DAMP) revealed that M1, M2, M3 subtypes were involved in [Ca2+]i changes. The PLC inhibitor U-73122 (10 µM) abolished OxoM-elicited Ca2+ responses in the presence of the M2 antagonist AF-DX 116, suggesting that M1, M3, or M5 mediates [Ca2+]i increases via PLC pathway. ACh (0.1 µM), Musc (10 µM), oxotremorine sesquifumarate (20 µM), and McN-A-343 (1 µM) acting on M1, M2, and M3 mAChR subtypes stimulated ATP release from cultured urothelial cells. In summary, cultured urothelial cells express functional M1, M2, and M3 mAChR subtypes whose activation results in ATP release, possibly through mechanisms involving [Ca2+]i changes.

bladder; Fura-2 calcium imaging; ATP



Address for reprint requests and other correspondence: F. Aura Kullmann, Dept. of Pharmacology, Univ. of Pittsburgh School of Medicine, E 1340 Biomedical Science Tower, Pittsburgh, PA 15261 (e-mail: flnst2{at}pitt.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.